SantéDige is a private foundation that supports the development of research on digestive diseases and is dedicated to advancing patient care in prevention, diagnosis, and treatment.
For many years, the SantéDige Foundation has embodied a joint commitment to corporate philanthropy. Today, 13 companies — Tipiak, Sodebo, GROSSERON SAS, CIC, FUJIFILM France (Medical Systems), Celltrion Inc, Mast Group Ltd, Asept InMed, Creo Medical, Provepharm, Sandoz France, and Guemas — provide their support to the Institute of Digestive Diseases at the Nantes University Hospital (IMAD). In the past, other sponsors such as Janssen-Cilag SA, Covidien, Ouest Alu, Archi Urba Deco, Maunakea Technologies, and Ernest Soulard have also contributed to the Foundation.
Established in July 2008, SantéDige brings together companies that recognize the major societal challenge represented by digestive health, with a strong commitment to advancing research in the field of digestive diseases, for the benefit of patients and the wider community.
Through its financial support, SantéDige contributes to the implementation of innovative research projects, training programs for healthcare professionals, and patient education initiatives.
The SantéDige Corporate Foundation supports the Institute of Digestive Diseases in Nantes (IMAD).
The joint commitment of various stakeholders — SantéDige sponsors and IMAD specialists — aims to accelerate medical progress in the prevention, diagnosis, and treatment of digestive diseases.
SantéDige provides IMAD with additional resources that can be mobilized quickly. Thanks to its flexibility in management, stability, and independence, SantéDige creates optimal conditions for excellence in research and for innovation.
“Born from our determination to advance research in the service of digestive health, the SantéDige Foundation embodies a new way of doing business — one that adds a social dimension to our corporate mission. In a civic-minded approach, SantéDige’s sponsors stand alongside the researchers and physicians of the Institute of Digestive Diseases (IMAD) at Nantes University Hospital, to improve the prevention, diagnosis, and treatment of digestive diseases. The Foundation is dedicated to strengthening ties between the business community and medical, scientific, and academic institutions, particularly in research, education, and initiatives that directly benefit patients. Our actions are carried out with full respect for the ethics and public service mission of IMAD, with excellence, rigor, and a commitment to innovation at the heart of our efforts.”
The Foundation is open to any company wishing to join forces with IMAD at Nantes University Hospital to advance research and the management of digestive diseases.
Digestive diseases are on the rise, with a high human and societal cost, and represent a major public health challenge.
Digestive cancers, Crohn’s disease, ulcerative colitis, diseases linked to hepatitis B and C viruses or to alcohol, digestive emergencies, disorders related to obesity, and even digestive complications of neurodegenerative diseases (such as Parkinson’s disease)… Today, nearly 2 in 10 people in France suffer from at least one digestive disease — a figure expected to grow in the coming years, notably due to population aging.
On the principle of shared commitment and values, the Foundation offers companies the opportunity to pool their philanthropic efforts to support a major public health challenge.
The Foundation is one of the pillars of innovation and of advancing research excellence within IMAD. By supporting the Foundation, you contribute to the implementation of original research projects, training programs for researchers and healthcare professionals, and patient education initiatives.
